REMIFENTANIL FOR INTRAVENOUS INJECTION 5mg "DAIICHI SANKYO" (レミフェンタニル静注用5mg「第一三共」)

Riik: Jaapan

keel: inglise

Allikas: すりの適正使用協議会 RAD-AR Council, Japan

Osta kohe

Laadi alla Infovoldik (PIL)
01-08-2022

Toimeaine:

Remifentanil hydrochloride

Saadav alates:

DAIICHI SANKYO COMPANY, LIMITED

INN (Rahvusvaheline Nimetus):

Remifentanil hydrochloride

Ravimvorm:

injection

Infovoldik

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 08/2022
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
REMIFENTANIL FOR INTRAVENOUS INJECTION
5MG "DAIICHI SANKYO"
ACTIVE INGREDIENT:
Remifentanil hydrochloride
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
photo image of the
medicine will be here
EFFECTS OF THIS MEDICINE
This medicine acts on opioid receptors and has a potent analgesic
effect.
It is usually used to relieve pain during operation under general
anesthetic or during artificial
respiration in intensive care.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you are within 1 week after stopping nalmefene hydrochloride.
If you recognize the weakness in physical strength.
If you have symptoms of hypovolemia (shock, pallor, cold sweat,
weakness, decreased body
temperature and blood pressure, tachycardia, respiratory failure,
cyanosis, and disturbed
consciousness), any disorders of the heart or blood vessels, such as
high blood pressure and
trouble in opening/ closing the valves of the heart, arrhythmia, any
failure in respiratory
function such as chronic lung disease, or asthma.
If you have experienced to not be able to stop taking the medicine
when you need to
discontinue the administration, or convulsive seizures.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other presc
                                
                                Lugege kogu dokumenti